Annual Review of Cancer Biology

The Annual Review of Cancer Biology is an annual review journal published by Annual Reviews since 2017 that surveys important and emerging areas of cancer research, with a 2025 Journal Impact Factor of 5.5.《癌症生物学年度综述》（Annual Review of Cancer Biology）由（Annual Reviews）出版，2017 年创办，为年刊综述期刊，综述癌症研究的重要与新兴领域，2025 年影响因子为 5.5。

Scope

• The journal reviews subjects across cancer research that represent important and emerging areas of the field.本刊综述癌症研究中具有重要意义与新兴方向的课题。
• The content is organised around three broad themes, beginning with cancer cell biology.其内容围绕三大主题组织，首先是肿瘤细胞生物学。
• Tumorigenesis and cancer progression form the second theme.肿瘤发生与癌症进展构成第二个主题。
• Translational cancer science, including targeted treatments, is the third theme.转化肿瘤科学，包括靶向治疗，是第三个主题。
• Reviews of the basic mechanisms of cancer development are published.关于癌症发生基础机制的综述均予发表。
• Emerging therapeutic approaches and their translation into the clinic are covered.新兴治疗手段及其向临床的转化均有收录。
• Each volume gathers invited reviews written by leading investigators.每卷汇集由知名研究者撰写的约稿综述。

History

• The Annual Review of Cancer Biology published its first volume in 2017.《癌症生物学年度综述》于 2017 年出版第 1 卷。
• It was the 47th journal in the Annual Reviews collection.本刊是（Annual Reviews）期刊系列中的第 47 种。
• It was founded by Tyler Jacks and Charles L. Sawyers.本刊由 Tyler Jacks 与 Charles L. Sawyers 创办。
• The journal has been published open access under the Subscribe to Open model since 2020.自 2020 年起，本刊以「订阅转开放」模式开放获取出版。
• It appears once a year and publishes a modest number of articles per volume.本刊每年出版一卷，每卷篇数不多。
• Its impact factor stood at 13.34 in 2022, 6.1 in 2024 and 5.5 in 2025.其影响因子在 2022 年为 13.34，2024 年为 6.1，2025 年为 5.5。

Editors

• Laura Attardi of Stanford University serves as co-editor.斯坦福大学的 Laura Attardi 担任共同主编。
• Scott A. Armstrong serves as the other co-editor.Scott A. Armstrong 担任另一位共同主编。
• The founding editors were Tyler Jacks and Charles L. Sawyers.创刊主编为 Tyler Jacks 与 Charles L. Sawyers。
• Reviews are commissioned by an editorial committee made up of senior cancer researchers.综述由资深肿瘤研究者组成的编辑委员会约稿。
• Proposals for topics may be submitted to the editors for consideration.选题建议可提交编辑考虑。
• Because the journal publishes only reviews, no primary research articles are considered.由于本刊只刊载综述，不接受原始研究论文。